Peripheral Neuropathy Trial, Recruiting (NCT07425275)

Peripheral Neuropathy Trial, Recruiting NCT07425275 Sponsor: Khyber Medical University Peshawar Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07425275 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The person has a single stone located in the renal pelvis (a specific part of the kidney where urine collects before moving to the ureter).
The person is under 18 years of age.
The person has no birth defects or other conditions affecting the shape or function of the urinary tract.
The person has no existing chest or lung conditions, such as chronic lung disease or fluid around the lungs.

Who may not be able to join:

People who have more than one kidney stone.
People whose stone is located in a calyx (a cup-shaped area within the kidney, rather than the central collecting area).
People who have a blockage where the kidney meets the ureter (the tube leading from the kidney to the bladder), a condition known as pelviureteric junction obstruction.
People whose kidney is located in an abnormal position in the body, such as in the pelvis rather than the usual place in the back (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr. Mahdia Babak, BDS, MPH, Institute of Public Health, Khyber Medical University (KMU), Peshawar, Pakistan

Phone: +92 331 0066683

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07425275

Sponsor: Khyber Medical University Peshawar

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +92 331 0066683

More information: https://clinicaltrials.gov/study/NCT07425275

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The person has a single stone located in the renal pelvis (a specific part of the kidney where urine collects before moving to the ureter).
The person is under 18 years of age.
The person has no birth defects or other conditions affecting the shape or function of the urinary tract.
The person has no existing chest or lung conditions, such as chronic lung disease or fluid around the lungs.

Who may not be able to join:

People who have more than one kidney stone.
People whose stone is located in a calyx (a cup-shaped area within the kidney, rather than the central collecting area).
People who have a blockage where the kidney meets the ureter (the tube leading from the kidney to the bladder), a condition known as pelviureteric junction obstruction.
People whose kidney is located in an abnormal position in the body, such as in the pelvis rather than the usual place in the back (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Khyber Medical University Peshawar

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

25 June 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Change in Xerostomia Severity Score; Change in Oral Health-Related Quality of Life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov